Cat. No. 3834
Chemical Name: (±)-2-(1H-benzimidazol-2-ylthio)prop
Biological ActivitySelective soluble adenylyl cyclase (sAC) inhibitor (IC50 = 3 - 10 μM in vivo). Inert towards transmembrane adenylyl cyclase (tmAC) in vitro and in whole cells at concentrations up to 300 μM. Blocks synthesis of cAMP and displays an antiapoptotic effect at concentrations of 1 - 100 μM.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Kumar et al (2009) Soluble adenylyl cyclase controls mitochondria-dependent apoptosis in coronary endothelial cells. J.Biol.Chem. 284 14760. PMID: 19336406.
Stessin et al (2006) Soluble adenylyl cyclase mediates nerve growth factor-induced activation of Rap1. J.Biol.Chem. 281 17253. PMID: 16627466.
Hess et al (2005) The 'soluble' adenylyl cyclase in sperm mediates multiple signaling events required for fertilization. Develop.Cell 9 249.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for KH 7 include:
Jahchan et al (2013) A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov 3 1364. PMID: 24078773.
Lee et al (2012) The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492 123. PMID: 23143333.
Do you know of a great paper that uses KH 7 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: KH 7, supplier, selective, adenylyl, cyclases, inhibitors, inhibits, soluble, sAC, KH7, Tocris Bioscience, Adenylyl Cyclase Inhibitor products
Find multiple products by catalog number
October 30 - November 3, 2016
Boston, MA, USA